VALSARTAN

作品数：113被引量：285H指数：9
导出分析报告
相关作者：白小涓单海燕苏彦君陈香美韦金儒更多>>
相关机构：河北医科大学皖南医学院弋矶山医院南京医科大学中国医科大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金湖北省自然科学基金国家重点基础研究发展计划中华医学会临床医学科研专项资金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
AGTR1 A1166C gene polymorphism is associated with the effectiveness of valsartan monotherapy in Chinese patients with essential hypertension:A retrospective analysis
《Asian Pacific Journal of Tropical Medicine》2024年第9期418-424,共7页Hanzhong Yu Lei Li Shuyao Wei Qianqian Kong Wei Nu Bo Dong Yuewu Zhao Li Wang 
Science and Technology Key Project of Xuzhou Municipal Health Commission,Jiangsu Province,China(XWKYHT20210531);Pengcheng Yingcai-Medical Young Reserve Talent Programme(XWRCHT20220013).
Objective:To investigate whether angiotensinⅡtype 1 receptor(AGTR1 A1166C)gene polymorphism was associated with the effectiveness of valsartan monotherapy in Chinese patients with essential hypertension.Methods:This ...
关键词：Essential hypertension AngiotensinⅡtype 1 receptor antagonist VALSARTAN AGTR1 A1166C Gene polymorphism 
Efficacy and safety of sacubitril-valsartan in lowering blood pressure in non-dialysis-dependent patients with stage 3-5 chronic kidney disease
《China Medical Abstracts(Internal Medicine)》2024年第3期182-183,共2页YAN Yu 
Objective To evaluate the efficacy and safety of sacubitril-valsartan (SV) in reducing blood pressure in patients with non-dialysis-dependent chronic kidney disease(NDD-CKD) stage 3-5 and concomitant hypertension.
关键词：DIALYSIS PATIENTS KIDNEY 
Effect of Angiotensin Receptor-neprilysin Inhibitor on Acute Kidney Injury in Patients With Acute Decompensated Heart Failure
《Cardiology Discovery》2024年第1期23-29,共7页Gonghao Li Yanli Zhao Zhongxing Peng Kun Liu Delu Yin Yunfeng Zhao 
supported by the First People’s Hospital of Lianyungang Talent Fund(QN202003);the Research and Development Fund of Kangda College of Nanjing Medical University(KD2022KYJJZD068).
Objective:The risk of acute kidney injury(AKI)is high in patients with acute decompensated heart failure(ADHF).The aim of this study is to analyze the role of urinary neutrophil gelatinase-associated lipocalin(uNGAL)i...
关键词：Acute kidney injury Acute decompensated heart failure Angiotensin receptor-neprilysin inhibitor Angiotensin-converting enzyme inhibitor Sacubitril valsartan BENAZEPRIL 
Effect of Guanxin-V Mixture Combined with Sacubitril Valsartan on Cardiac Function after PCI in STEMI Patients
《Medicinal Plant》2024年第1期75-78,共4页Zhiliang CHEN Wei ZHANG Jun GONG Feng KE Ning GU 
Supported by National Natural Science Foundation of China(81774229);Nanjing Chinese Medicine Young Talent Cultivation Program(ZYQ20027);Natural Science Foundation of Nanjing University of Chinese Medicine(XZR2021052);Discipline(Academic)Reserve Talent Training Program of Nanjing Hospital of Chinese Medicine(YRC2016-CZL);Nanjing Traditional Chinese Medicine Science and Technology Special Fund Project(ZYQN202203);Traditional Chinese Medicine Preparation Research Project in Nanjing Medical Institutions(NJCC-ZJ-202315).
[Objectives]To observe the effect of Guanxin-V Mixture combined with Sacubitril Valsartan on cardiac function in patients after PCI for acute ST-segment elevation myocardial infarction(STE-MI).[Methods]41 cases of STE...
关键词：Guanxin-V Mixture Sacubitril Valsartan Acute ST-segment elevation myocardial infarction PCI Heart failure 
Evaluation of the Effectiveness and Efficiency of the Combination of Levamlodipine Besylate and Valsartan in the Treatment of Hypertension
《Proceedings of Anticancer Research》2024年第1期92-98,共7页Dazhuan Li 
Objective:To investigate the effectiveness and efficiency of combining levamlodipine besylate and valsartan in the treatment of hypertension.Methods:This study selected 28 patients with hypertension as observation sub...
关键词：Levamlodipine besylate VALSARTAN HYPERTENSION Renal function Effective rate 
Efficacy and safety of sacubitril/valsartan after six months in patients with heart failure with reduced ejection fraction and asymptomatic hypotension被引量：2
《Journal of Geriatric Cardiology》2023年第12期855-866,共12页An-Hu WU Zong-Wei LIN Zhuo-Hao YANG Hui ZHANG Jia-Yi HU Yi WANG Rui TANG Xin-Yu ZHANG Xiao-Ping JI Hui-Xia LU 
supported by the National Natural Science Foundation of China(No.81873516&No.821704-63);the National Key Research and Development Program of China(2021YFF0501404&2021YFF0501403&2017YFC1308303);the Natural Science Foundation of Shandong Province(ZR2019PH030&ZR2019BH052);the China International Medical Foundation(Z-2019-42-1908-2).
BACKGROUND It is not clear whether sacubitril/valsartan is beneficial for patients with heart failure(HF)with reduced ejec-tion fraction(HFrEF)and low systolic blood pressure(SBP).This study aimed to investigate the e...
关键词：PATIENTS HYPOTENSION DOSAGE 
Efficacy and safety of oral Chinese patent medicine combined with sacubitril/valsartan in the treatment of chronic heart failure:A Metaanalysis
《Journal of Hainan Medical University》2023年第16期52-60,共9页TAO Shi-yi TANG Xian-wen ZHANG Lan-xin YU Lin-tong ZHANG Jin YANG Deshuang LI Ling-ling HUANG Li WU Jia-yun 
National Natural Science Foundation of China (No.81803925);National Key Research and Development Program (No.2017YFC1700102)。
Objective:To systematically evaluate the clinical efficacy of oral Chinese patent medicine combined with sacubitril/valsartan in treating chronic heart failure(CHF).Methods:CNKI,CSPD,CCD,CBM,PubMed,Web of Science,Coch...
关键词：Oral Chinese patent medicine Sacubitril/valsartan Angiotensin receptor-neprilysin inhibitor Chronic heart failure Qili Qiangxin Capsule Qishen Yiqi Pill Dengzhan Shengmai Capsule 
Early initiation of ARBs without blood pressure risk via neutrophil membrane-fused pH-sensitive liposomes to reduce cardiomyocyte apoptosis after acute myocardial infarction被引量：1
《Nano Research》2023年第7期9894-9905,共12页Jinfeng Gao Wusiman Yakufu Hongbo Yang Yanan Song Qiaozi Wang Qiyu Li Haipeng Tan Jing Chen Dili Sun Zhengmin Wang Jinyan Zhang Xueyi Weng Juying Qian Zhiqing Pang Qibing Wang Zheyong Huang Junbo Ge 
The authors thank the Shiyanjia Lab(www.shiyanjia.com)for TEM measurements.The authors are grateful to Ms.Xiao Guo at the Joint Live Small Animal Imaging Laboratory of Fudan University Shanghai Medical College-PerkinElmer Company,for her technical support with the use of the in vivo imaging system.This work was financially supported by the National Key Research and Development Program of China(No.2016YFC1301200);the National Natural Science Foundation of China(Nos.82070281,81870269,and 82170524);Shanghai Clinical Research Center for Interventional Medicine(No.19MC1910300).
Activation of the local renin-angiotensin system(RAS)promotes cardiomyocyte apoptosis and cardiac remodeling after acute myocardial infarction(AMI).As an anti-RAS drug,the effect of Valsartan in the early stage of acu...
关键词：VALSARTAN early initiation cardiomyocyte apoptosis blood pressure myocardial infarction 
Research progress of sacubitril/valsartan in heart failure patients with preserved ejection fraction被引量：2
《Journal of Chinese Pharmaceutical Sciences》2022年第6期471-477,共7页Jingjing Cao Shujuan Zhao Chenglong Zhao Peizhi Ma 
With the launch of sacubitril/valsartan(ARNI),there are new options for the treatment of heart failure(HF).However,ARNI is currently only used in HF patients with reduced ejection fraction(HFrEF).No evidence shows tha...
关键词：Preserved ejection fraction Reduced ejection fraction Sacubitril/valsartan 
Effect of Sacubitril-Valsartan Combined with Zhenyuan Capsule in the Treatment of Chronic Heart Failure Comorbid Anxiety and Depression and Its Effect on Inflammatory Factors被引量：1
《Natural Science》2022年第6期241-250,共10页Jianhong Qin Wenzhi Mo Lixin Xie Erneng Zhou Guijiao Li Rongfu Liang Xuenuo Wu 
Objective: To investigate the effect of sacubitril-valsartan combined with Zhenyuan capsule in the treatment of chronic heart failure comorbid anxiety and depression and its effect on the level of inflammatory factors...
关键词：Heart Failure ANXIETY DEPRESSION Sacubitril Valsartan Zhenyuan Capsule Inflammatory Factors 
全选清除导出
共12页<12345678910>
检索报告 对象比较 聚类工具 使用帮助 返回顶部